(Q42426461)

31 October 2017

title

Tafazzin knockdown causes hypertrophy of neonatal ventricular myocytes (English)

1 reference

31 October 2017

Quan He

1

1 reference

31 October 2017

publication date

26 March 2010

1 reference

American Journal of Physiology Heart and Circulatory Physiology

31 October 2017

published in

1 reference

31 October 2017

volume

299

1 reference

31 October 2017

issue

1

1 reference

31 October 2017

page(s)

H210-6

1 reference

Multiple signaling pathways coordinately mediate reactive oxygen species dependent cardiomyocyte hypertrophy

31 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

X-linked cardioskeletal myopathy and neutropenia (Barth syndrome) (MIM 302060)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

A novel X-linked gene, G4.5. is responsible for Barth syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

Inhibitory effect of resveratrol on angiotensin II-induced cardiomyocyte hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

Role of mitogen-activated protein kinase pathway in reactive oxygen species-mediated endothelin-1-induced beta-myosin heavy chain gene expression and cardiomyocyte hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

Role of cardiolipin alterations in mitochondrial dysfunction and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

The cardiolipin transacylase, tafazzin, associates with two distinct respiratory components providing insight into Barth syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

Insulin-resistant heart exhibits a mitochondrial biogenic response driven by the peroxisome proliferator-activated receptor-alpha/PGC-1alpha gene regulatory pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

Contractile and cytoskeletal content, structure, and mRNA levels with tachycardia-induced cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

Structural remodeling and mechanical dysfunction of cardiac myocytes in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

Regulation of mitochondrial proliferation in the heart: power-plant failure contributes to cardiac failure in hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

Aberrant cardiolipin metabolism in the yeast taz1 mutant: a model for Barth syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

Gene expression profiling of dilated cardiomyopathy in older male EP4 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

Effects of interleukin-1 beta and nitric oxide on cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

Post-translational regulation of phosphatidylglycerolphosphate synthase in response to inositol

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

PKA, Rap1, ERK1/2, and p90RSK mediate PGE2 and EP4 signaling in neonatal ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

Interleukin-1beta regulation of the human brain natriuretic peptide promoter involves Ras-, Rac-, and p38 kinase-dependent pathways in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

Src and Rac mediate endothelin-1 and lysophosphatidic acid stimulation of the human brain natriuretic peptide promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

Involvement of reactive oxygen species-mediated NF-kappa B activation in TNF-alpha-induced cardiomyocyte hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

Absence of cardiolipin in the crd1 null mutant results in decreased mitochondrial membrane potential and reduced mitochondrial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

Cellular functions of cardiolipin in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

A zebrafish model of human Barth syndrome reveals the essential role of tafazzin in cardiac development and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

Tissue-specific expression of the human brain natriuretic peptide gene in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

The human TAZ gene complements mitochondrial dysfunction in the yeast taz1Delta mutant. Implications for Barth syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

Assessing mitochondria biogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

Cytochrome c release from mitochondria proceeds by a two-step process

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

The role of AMP-activated protein kinase in mitochondrial biogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

AMPK and the biochemistry of exercise: implications for human health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

Cardiolipin biosynthesis and remodeling enzymes are altered during development of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

Phospholipid abnormalities in children with Barth syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

Deficiency of tetralinoleoyl-cardiolipin in Barth syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

Cardiac and clinical phenotype in Barth syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

High mitochondrial densities in the hearts of Antarctic icefishes are maintained by an increase in mitochondrial size rather than mitochondrial biogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

Cardiolipin deficiency in X-linked cardioskeletal myopathy and neutropenia (Barth syndrome, MIM 302060): a study in cultured skin fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

Leptin induces hypertrophy via endothelin-1-reactive oxygen species pathway in cultured neonatal rat cardiomyocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

A Drosophila model of Barth syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

The enzymatic function of tafazzin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

Characterization of lymphoblast mitochondria from patients with Barth syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

Acute metabolic decompensation and sudden death in Barth syndrome: report of a family and a literature review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00098.2010

10.1152/AJPHEART.00098.2010

21 January 2018

Identifiers

DOI

1 reference

31 October 2017

1 reference